Unibest

管线数据库

UB500

Thymopentin Injection

提交项目新药候选物数据库

UB500

ProductThymopentin Injection
Strength(1)1 mg,10 mg (Thymopentin for injection);(2)1 ml:1 mg,1 ml:10 mg(Thymopentin injection);(3)1 ml:1mg,1 ml:10 mg(Thymopentin prefilled injection)
IndicationsNeoplasm; Hepatitis acute; Hepatitis chronic; T-cell immunodeficiency; Autoimmune disorder; Cell-mediated immunodeficiency
TherapeuticsImmunology & Inflammation
GMPPIC/S
RegistrationChina
ModalitiesPeptide

Exclusive Summary

  • - Fully off-patent globally, enabling rapid multi-country entry as a mature generic.
  • - Targets large immunomodulation needs in older adults (≈771M aged 65+) and chronic HBV (≈254M) with a low-cost injectable option.
  • - PIC/S GMP plus prefilled syringe (1 mg/10 mg) enhances compliance and ease-of-use for hospital tenders and distribution.
  • - Synthetic pentapeptide manufacturing delivers substantial cost advantage versus biologic immunomodulators.
  • - Limited competition outside China creates a differentiation and early-entry window in CIS/MENA/LATAM markets.

Asset Materials

UB500 Asset Materials

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →